Industry: Pharmaceuticals, Biotechnology
Synthetic Genomics, Inc. was founded in 2005 to develop and commercialize synthetic biology. The Company is applying recent scientific advances, including newly discovered genetic sequences of novel photosynthetic and metabolic pathways, to execute various life functions within a synthetically devised organism. These breakthroughs present unprecedented opportunities that could restructure and revolutionize industries including energy, industrial organic compounds, pharmaceuticals, CO2 sequestration, fine chemicals, and environmental remediation. Synthetic Genomics, Inc.’s initial focus will be on new approaches to biological energy production. ( www.syntheticgenomics.com )
Synthetic Genomics , Inc.
9601 Blackwell Road Suite 200
Rockville, Maryland 20850
USA
Tel: (240) 238-0800
Fax: (240) 268-3818